[1]
2026. Clinical Evaluation of APRI as a Non-Invasive Screening Tool for Liver Fibrosis and Cirrhosis in Faisalabad, Punjab, Pakistan. Pakistan Journal of Medical & Cardiological Review. 5, 2 (Jun. 2026), 4664–4673. DOI:https://doi.org/10.66021/pakmcr1347.